YOLFTbeta
B1

YSB Inc.

B1S · F · Healthcare / Pharmaceutical Retailers

0.352EUR-0.00 (-1.12%)

Price History

Full chart

Market Stats

Previous Close0.356
Open0.352
Day Range0.352 – 0.352
52-Week Range0.302 – 1.25
Volume0
Market Cap244.67M
P/E (TTM)8.90
Forward P/E0.00
EPS0.04
Dividend Yield3.98%
Beta0.44
50-Day Avg0.3473
200-Day Avg0.4509

About

YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that includes Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations. In addition, the company engages in the wholesale and retail of pharmaceutical and healthcare products. Further, it provides medical testing services; logistics services; and ClouDiagnos. YSB Inc. was founded in 2015 and is headquartered in Guangzhou, China.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMr. Buzhen Zhang
  • Employees6.79K
  • HeadquartersYaoshibang Building, Guangzhou, China, Germany
  • Websitehttps://www.ysbang.cn

Leadership

  • Mr. Buzhen ZhangCEO & Executive Chairman · b. 1975
  • Mr. Fei ChenCFO, Executive Director & Joint Company Secretary · b. 1984
  • Mr. Zhuoqi ChenChief Technology Officer · b. 1979
  • Ms. Wai Sum Fung A.C.I.S., A.C.S.Joint Company Secretary · b. 1983
  • Mr. Haodong XiaoVice President · b. 1973

Financials

Income Statement

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue10.09B14.27B16.97B17.90B20.97B
Growth (%)-+41.43%+18.90%+5.49%+17.13%
Cost of Revenue9.18B12.84B15.23B16.09B18.66B
Gross Profit913.83M1.43B1.74B1.81B2.31B
Gross Margin9.05%10.05%10.26%10.13%11.00%
Operating Expense1.32B1.67B1.79B1.90B2.24B
Operating Income-401.33M-235.99M-48.94M-83.56M69.53M
Operating Margin-3.98%-1.65%-0.29%-0.47%0.33%
EBITDA--1.35B-3.07B154.29M301.69M
EBITDA Margin--9.47%-18.07%0.86%1.44%
Net Income-501.62M-1.50B-3.21B30.01M152.97M
Net Income Margin-4.97%-10.51%-18.89%0.17%0.73%
R&D56.61M79.15M93.60M94.19M95.66M
R&D as % of Total Revenue0.56%0.55%0.55%0.53%0.46%
Interest Expense8.49M10.23M10.03M11.34M11.93M
Interest Expense % of Total Revenue0.08%0.07%0.06%0.06%0.06%

Balance Sheet

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.44B4.11B5.21B6.50B7.56B
Total Liabilities6.35B8.48B3.33B4.23B5.18B
Total Equity-2.90B-4.35B1.92B2.32B2.44B
Cash383.60M835.39M673.87M1.01B706.87M
Net Debt184.93M----

Cash Flow

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-487.09M98.20M451.20M655.86M637.70M
Capital Expenditure120.97M43.71M17.55M23.40M18.24M
Free Cash Flow-608.06M54.49M433.65M632.46M619.46M
Dividends Paid----50.79M
FCF to OCF124.84%55.49%96.11%96.43%97.14%
Dividend Paid to FCF----8.20%

Key Statistics & Ratios

Market Cap244.67M
Enterprise Value73.34M
Trailing P/E8.90
Forward P/E0.00
Price / Sales0.01
Price / Book0.78
EPS0.04
Book Value0.4637
Revenue (TTM)21.41B
Gross Profit (TTM)2.35B
EBITDA172.92M
Profit Margin0.87%
Operating Margin0.75%
Return on Equity7.86%
Return on Assets0.90%
Shares Outstanding687.28M
Shares Float322.34M
Beta0.44
Dividend Yield3.98%
Dividend Rate0.01
Payout Ratio39.97%

Dividends

20261×
0.01May 26, 2026
20251×
0.01May 23, 2025